Impaired lipoprotein catabolism in hemodialysis patients
Carol Lovegrove
This article has no abstract so we have provided the first paragraph of the full text.
An increased risk of premature cardiovascular disease has long been recognized in patients with end-stage renal disease treated by hemodialysis. A large number of factors have been associated with this increased risk, including dyslipoproteinemia, however, despite an obviously impaired lipoprotein metabolism, LDL levels are not generally increased.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
